All Stories

  1. Gene and Cellular Therapies for Leukodystrophies
  2. Non-Myelotoxic Agents as a Preparatory Regimen for Hematopoietic Stem Cell Gene Therapy
  3. The Role of Rab GTPases in the development of genetic and malignant diseases
  4. Global miRNA expression of bone marrow mesenchymal stem/stromal cells derived from Fanconi anemia patients
  5. Effects of storage media, supplements and cryopreservation methods on quality of stem cells
  6. Strategies to Protect Hematopoietic Stem Cells from Culture-induced Stress Conditions
  7. Development, characterization, and hematopoietic differentiation of Griscelli syndrome type 2 induced pluripotent stem cells
  8. Comparison of immune modulatory properties of human multipotent mesenchymal stromal cells derived from bone marrow and placenta
  9. G-CSF treatment of healthy pediatric donors affects their hematopoietic microenvironment through changes in bone marrow plasma cytokines and stromal cells
  10. CXCR4 expression by mesenchymal stromal cells is lost after use of enzymatic dissociation agents, but preserved by use of non-enzymatic methods
  11. Generation and Hematopoietic Differentiation of Mesenchymal Stromal/Stem Cell-Derived Induced Pluripotent Stem Cell Lines for Disease Modeling of Hematopoietic and Immunological Diseases
  12. Stem Cell Applications in Lysosomal Storage Disorders: Progress and Ongoing Challenges
  13. Neuropeptide Y is involved in the regulation of quiescence of hematopoietic stem cells
  14. SUL-109 Protects Hematopoietic Stem Cells from Apoptosis Induced by Short-Term Hypothermic Preservation and Maintains Their Engraftment Potential
  15. Characterization of mesenchymal stem cells in mucolipidosis type II (I-cell disease)
  16. HEMATOPOIETIC STEM CELL GENE THERAPY FOR INHERITED MONOGENIC DISEASES AND ITS IMPLICATIONS FOR FUTURE GENE THERAPY TRIALS IN TURKEY
  17. Neurological Regulation of the Bone Marrow Niche
  18. B lymphocyte subsets and outcomes in patients with an initial diagnosis of transient hypogammaglobulinemia of infancy
  19. Bone marrow mesenchymal stem cell donors with a high body mass index display elevated endoplasmic reticulum stress and are functionally impaired
  20. Automated washing of long-term cryopreserved peripheral blood stem cells promotes cell viability and preserves CD34+ cell numbers
  21. Human bone marrow mesenchymal stem cells secrete endocannabinoids that stimulate in vitro hematopoietic stem cell migration effectively comparable to beta-adrenergic stimulation
  22. Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-β1 Production
  23. Development and characterization of iPS cell lines from a patient with Griscelli type 2 disease
  24. Stably expressed reference genes during differentiation ofbone marrow-derived mesenchymal stromal cells
  25. Evaluation of biocompatibility of random or aligned electrospun polyhydroxybutyrate scaffolds combined with human mesenchymal stem cells
  26. Structural investigation of donor age effect on human bone marrow mesenchymal stem cells: FTIR spectroscopy and imaging
  27. Polymeric scaffolds with different alignment and their interactions with bone marrow-derived mesenchymal stem cells
  28. Assessment of human bone marrow plasma samples suggests a different role for mesenchymal stromal cells in distinct areas mediated by PDGF-BB/PDGF-R
  29. Differential cytokine expression profile of healthy human bone marrow plasma samples from the endosteal and vascular region
  30. Differential miRNA expression profile of bone marrow derived mesenchymal stem cells in fanconi anemia patients and healthy donors
  31. Effects of in-vivo G-CSF stimulation on cytokine levels in bone marrow plasma samples from healthy donors
  32. Iron oxide nanoparticle labeling of mesenchymal stromal cells
  33. Lactic acid bacteria can reduce TLR-4 expression on inflammated gingival fibroblasts and mesenchymal stem cells in vitro
  34. 5-Androstene-3β,17β-diol Promotes Recovery of Immature Hematopoietic Cells Following Myelosuppressive Radiation and Synergizes With Thrombopoietin
  35. Keratinocyte Growth Factor and Stem Cell Factor to Improve Thymopoiesis after Autologous CD34+ Cell Transplantation in Rhesus Macaques
  36. Mobilization of hepatic mesenchymal stem cells from human liver grafts
  37. Lentiviral gene therapy of murine hematopoietic stem cells ameliorates the Pompe disease phenotype
  38. Adipocyte differentiation defect in mesenchymal stromal cells of patients with malignant infantile osteopetrosis